Posted by IMARC Group, a leading market research company, has recently releases report titled “Macular Degeneration Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global macular degeneration treatment market growth, trends, share, size and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How Big is the Macular Degeneration Treatment Market?
The global macular degeneration treatment market size reached US$ 8.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.9 Billion by 2028, exhibiting a growth rate (CAGR) of 6.2% during 2023-2028.
What are Macular Degeneration Treatment?
Macular degeneration is a medical condition that affects the eyes and causes blurriness and loss of vision in the center of the visual field. The treatment of macular degradation depends on the type and severity of the condition, including dry age-related and wet age-related macular degeneration. It helps to slow the progression of macular degeneration, preserve vision, and prevent further loss of vision. At present, macular degeneration treatment is gaining traction as it helps individuals to maintain their independence and perform daily activities.
Request Free Sample Copy of This Report: https://www.imarcgroup.com/macular-degeneration-treatment-market/requestsample
What are the growth prospects and trends in the macular degeneration treatment industry?
The growing geriatric population and the increasing number of people affected by macular degeneration represent one of the key factors positively influencing the market. In addition, sedentary lifestyles and changing dietary patterns are resulting in the development of macular degeneration.
Apart from this, the increasing utilization of smartphones, laptops, and televisions, is also contributing to the occurrence of the disorder, which, in turn, is catalyzing the demand for macular degeneration treatment. Moreover, increasing patient awareness and education about macular degeneration and the growing knowledge about the importance of regular eye check-ups are strengthening the market growth.
Furthermore, advancements in diagnostic technologies, such as molecular imaging, that enable early detection of macular degeneration are stimulating the growth of the market worldwide.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Type:
- Dry Age-related Macular Degeneration
- Wet Age-related Macular Degeneration
Breakup by Stage of Disease:
- Early Stage
- Intermediate Stage
- Late Stage
Breakup by Route of Administration:
- Intravenous Route
- Intravitreal Route
Breakup by End User:
- Hospitals
- Ambulatory Surgical Center
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
Aerie Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Iveric Bio Inc., Novartis AG, Panoptica, Pfizer Inc., Phio Pharmaceuticals, Regeneron Pharmaceuticals Inc., Regenxbio Inc. and Santen Pharmaceutical Co. Ltd.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/